Related Content
May 25, 2023 — New data presented from an investigator-sponsored European trial found managing indicated1 heart failure ...
May 25, 2023 — First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic ...
May 25, 2023 — Abbott announced late-breaking results from the AVEIR dual-chamber (DR) i2i Investigational Device ...
May 24, 2023 — Stereotaxis announced a global collaboration with Abbott to integrate Abbott’s EnSite X EP System with ...
May 19, 2023 — Abbott announced late-breaking data that add to the body of clinical evidence supporting the benefits of ...
May 18, 2023 — Abbott announced its Assert-IQ insertable cardiac monitor (ICM) has received U.S. Food and Drug ...
March 31, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company's Epic Max ...
March 5, 2023 — Patients with complex coronary artery disease who underwent a stenting procedure guided by intravascular ...
March 5, 2023 — In patients with heart failure and a poorly functioning heart valve, a minimally invasive procedure ...
February 28, 2023 — On Feb. 27, the U.S. Food and Drug Administration (FDA) issued a Letter to Health Care Providers to ...